Last mentioned: Feb 24, 2026
Comment Period Close
Expected deadline for industry stakeholders to submit feedback on the proposed framework.
Customized Drug Proposal
FDA formally proposes the new system for approving bespoke therapies for rare diseases.
FDORA Enacted
The Food and Drug Omnibus Reform Act authorizes the FDA to establish a Platform Technology Designation.
Orphan Drug Act
Congress passes legislation providing financial incentives for rare disease research.
The FDA has proposed a landmark regulatory system designed to accelerate the approval of customized, 'bespoke' medicines for ultra-rare diseases. The framework allows manufacturers to leverage data from established platform technologies to streamline the development of individualized genomic treatments.